Our results also demonstrate that hepatic Sam68 deficiencies improve insulin sensitivity and reduce hyperglycemia in diabetic mice, which suggests that Sam68 could be a therapeutic target for the treatment of T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.